| Schedule of Deferred Tax Assets and Liabilities |
The following is a summary of the significant components of the Company’s net deferred income tax assets and liabilities as of December 31, 2021 and 2020:
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
|
|
2021 |
|
2020 |
Current deferred income tax assets: |
|
|
|
|
|
|
Accrued compensation and other |
|
|
11,000 |
|
|
11,000 |
Less: valuation allowance |
|
|
(11,000) |
|
|
(11,000) |
|
|
$ |
— |
|
$ |
— |
Non-current deferred income tax assets and (liabilities): |
|
|
|
|
|
|
Net operating loss |
|
$ |
13,013,000 |
|
$ |
12,003,000 |
Research and development credit |
|
|
18,000 |
|
|
18,000 |
Warrants issued for services |
|
|
45,000 |
|
|
45,000 |
Depreciation and amortization |
|
|
126,000 |
|
|
95,000 |
Exercise of options and warrants |
|
|
(33,000) |
|
|
(33,000) |
Stock based compensation |
|
|
1,028,000 |
|
|
957,000 |
Intangibles and other |
|
|
(606,000) |
|
|
(471,000) |
Less: valuation allowance |
|
|
(13,591,000) |
|
|
(12,614,000) |
Net non-current deferred tax assets |
|
$ |
— |
|
$ |
— |
|